Inside-V Tablet is a combination antimicrobial formulation containing Clindamycin (100 mg), Metronidazole (100 mg), and Clotrimazole (100 mg), designed for the effective treatment of mixed bacterial and fungal infections, particularly in gynecological and oral applications. Clindamycin, a lincosamide antibiotic, inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, exhibiting potent activity against anaerobic bacteria and certain aerobic Gram-positive organisms. Metronidazole, a nitroimidazole derivative, exerts bactericidal and antiprotozoal effects by disrupting DNA synthesis in anaerobic bacteria and protozoa. Clotrimazole, an imidazole antifungal agent, acts by inhibiting ergosterol synthesis, compromising fungal cell membrane integrity, thereby treating candidal infections. Inside-V Tablet is indicated for mixed infections where bacterial and fungal pathogens coexist, such as bacterial vaginosis complicated by candidiasis or oral thrush with secondary bacterial involvement. The combination therapy ensures broad-spectrum coverage, reducing the risk of resistance development and improving clinical outcomes. Dosage and duration should be determined by a healthcare professional based on infection severity and patient response. Caution is advised in patients with hypersensitivity to any component, hepatic impairment, or during pregnancy and lactation. Adverse effects may include gastrointestinal disturbances, hypersensitivity reactions, and local irritation. Proper adherence to prescribed regimen is essential for optimal therapeutic efficacy.